scholarly journals (+)-Discodermolide: A Marine Natural Product Against Cancer

2004 ◽  
Vol 4 ◽  
pp. 415-436 ◽  
Author(s):  
Marcus Viníus Nora De Souza

(+)-Discodermolide was isolated in 1990 by Gunasekera et al. from the deep-water Caribbean sponge Discodermia dissoluta. It attacks cancer cells in a similar way to the successful cancer drug Taxol® that has become the best-selling anticancer drug in history. Taxol is also the first natural product described that stabilizes the microtubules involved in many aspects of cellular biology and that represent an important target of anticancer chemotherapeutics. However, (+)-discodermolide appears to be far more potent than Taxol® against tumors that have developed multiple-drug resistance, with an IC50in the low nanomolar range. Due to these excellent results, this natural product was licensed to Novartis Pharmaceutical Corporation in early 1998. The present review covers the history, biological activity, total synthesis, and synthetic analogs of (+)-discodermolide.

2021 ◽  
Vol 11 ◽  
Author(s):  
Hui Shi ◽  
Yaoxiang Sun ◽  
Hongru Ruan ◽  
Cheng Ji ◽  
Jiahui Zhang ◽  
...  

Gastric cancer is a malignant tumor characterized by high morbidity and invasion. Surgery combined with chemo-radiotherapy is the most common treatment for gastric cancer, while multiple drug resistance always results in treatment failure. Once the anti-tumor drugs enter the tumor foci, tumor cells as well as those found in the microenvironment are affected. However, the effects of drugs on tumor microenvironment (TME) are easily overlooked. In this study, we investigated the effects of the anti-cancer drug 3,3’-diindolylmethane (DIM) on gastric cancer-derived mesenchymal stem cells (GC-MSCs) and their subsequent impact on cancer progression. Surprisingly, we found that the therapeutic concentration of DIM upregulated the expression level of tumor-related factors such as CCL-2, IL-6, and IL-8 in GC-MSCs. The conditioned medium of DIM-treated GC-MSCs promoted the proliferation, invasion, and migration of gastric cancer cells in vitro and tumor growth in vivo. Mechanistically, DIM enhanced the expression of β-TrCP, an E3 ubiquitin ligase leading to IκBα degradation and NF-κB activation in GC-MSCs. The β-TrCP knockdown partially eliminated positive results caused by DIM. Our results showed that the therapeutic dosage of DIM induced cell death in cancer cells, while enhancing MSC paracrine functions in the stroma to offset the original DIM effect on cancer cells. These findings provide a new mechanism of anti-cancer drug resistance and remind us to adjust the chemotherapeutic scheme by combining the anti-cancer drug with an appropriate signaling pathway inhibitor to block the side effects of drug on targeted TME cells.


2021 ◽  
Author(s):  
◽  
Jingjing Wang

<p>(-)-Zampanolide is a microtubule-stabilising marine natural product, with promise as a cancer drug candidate. The potential therapeutic application of zampanolide has fuelled worldwide interest in its total synthesis, but few analogue studies have been reported. Analogues afford the possibility of examining the structure-activity relationships with a view to optimising for potency and medicinal viability. This project seeks to devise a new route to zampanolide and generate a series of analogues for bioactivity evaluation.   The initial approach to zampanolide and a number of designed analogues was through disconnections at C20 by an N-aldol reaction, at C1 by Yamaguchi esterification, at C8-C9 by metathesis and at C15-C16 by alkynylation. During the development of fragment syntheses, problems were encountered with protection of the secondary hydroxyl group at C19 and establishment of an aldehyde at C15. Useful natural and analogue fragments were generated during this exploratory phase.  The order of connections was revised, and effort has been put towards the improvement of the synthetic efficiency. A three-component reaction involving (triphenylphosphoranylidene)-ketene, also known as Bestmann ylide, as a linchpin was envisaged to provide the dienoate of zampanolide. This is an expanded application of Bestmann ylide and therefore the scope of this linchpin reaction was investigated using simple alcohols and aldehydes. Success in the scoping study fortified this approach, and the coupling of the C3-C8 and C16-C20 fragments of zampanolide proceeded with good yields and stereoselectivity of the E,Z-geometry.  The planned late stage connections were tested on model substrates. The side arm attachment by a chiral boron reagent-promoted aza-aldol reaction failed to produce desired product on a simple model. However, model substrates that better account for the functionality of the zampanolide macrocycle are proposed for subsequent studies. In case these also do not succeed, reliable alternative methods described in the literature would be used. Several methods were scanned for the asymmetric alkynylation required for the C15-C16 bond connection. That involving ProPhenol and diethylzinc produced an excellent yield with a model alkyne. Although the stereoselectivity of the alkynylation is yet to be optimized, it was also tested on the full zampanolide fragment generated from the Bestmann ylide reaction. A small amount of the desired product was isolated, establishing 16 out of the 18 carbons of the macrocycle. Formation of a macrocycle is close at hand.</p>


2021 ◽  
Author(s):  
◽  
Jingjing Wang

<p>(-)-Zampanolide is a microtubule-stabilising marine natural product, with promise as a cancer drug candidate. The potential therapeutic application of zampanolide has fuelled worldwide interest in its total synthesis, but few analogue studies have been reported. Analogues afford the possibility of examining the structure-activity relationships with a view to optimising for potency and medicinal viability. This project seeks to devise a new route to zampanolide and generate a series of analogues for bioactivity evaluation.   The initial approach to zampanolide and a number of designed analogues was through disconnections at C20 by an N-aldol reaction, at C1 by Yamaguchi esterification, at C8-C9 by metathesis and at C15-C16 by alkynylation. During the development of fragment syntheses, problems were encountered with protection of the secondary hydroxyl group at C19 and establishment of an aldehyde at C15. Useful natural and analogue fragments were generated during this exploratory phase.  The order of connections was revised, and effort has been put towards the improvement of the synthetic efficiency. A three-component reaction involving (triphenylphosphoranylidene)-ketene, also known as Bestmann ylide, as a linchpin was envisaged to provide the dienoate of zampanolide. This is an expanded application of Bestmann ylide and therefore the scope of this linchpin reaction was investigated using simple alcohols and aldehydes. Success in the scoping study fortified this approach, and the coupling of the C3-C8 and C16-C20 fragments of zampanolide proceeded with good yields and stereoselectivity of the E,Z-geometry.  The planned late stage connections were tested on model substrates. The side arm attachment by a chiral boron reagent-promoted aza-aldol reaction failed to produce desired product on a simple model. However, model substrates that better account for the functionality of the zampanolide macrocycle are proposed for subsequent studies. In case these also do not succeed, reliable alternative methods described in the literature would be used. Several methods were scanned for the asymmetric alkynylation required for the C15-C16 bond connection. That involving ProPhenol and diethylzinc produced an excellent yield with a model alkyne. Although the stereoselectivity of the alkynylation is yet to be optimized, it was also tested on the full zampanolide fragment generated from the Bestmann ylide reaction. A small amount of the desired product was isolated, establishing 16 out of the 18 carbons of the macrocycle. Formation of a macrocycle is close at hand.</p>


2021 ◽  
Vol 12 ◽  
Author(s):  
Huan Xiao ◽  
Yongcheng Zheng ◽  
Lingling Ma ◽  
Lili Tian ◽  
Qiu Sun

Multiple drug resistance (MDR), referring to the resistance of cancer cells to a broad spectrum of structurally and mechanistically unrelated drugs across membranes, severely impairs the response to chemotherapy and leads to chemotherapy failure. Overexpression of ATP binding cassette (ABC) transporters is a major contributing factor resulting in MDR, which can recognize and mediate the efflux of diverse drugs from cancer cells, thereby decreasing intracellular drug concentration. Therefore, modulators of ABC transporter could be used in combination with standard chemotherapeutic anticancer drugs to augment the therapeutic efficacy. This review summarizes the recent advances of important cancer-related ABC transporters, focusing on their physiological functions, structures, and the development of new compounds as ABC transporter inhibitors.


Planta Medica ◽  
2013 ◽  
Vol 79 (10) ◽  
Author(s):  
M Albadry ◽  
Y Zou ◽  
Y Takahashi ◽  
A Waters ◽  
M Hossein ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document